GlassScriptPhysician profile
Jennifer D Ford
NPI 1629433099
$543.16
in general payments reported to CMS, 2019-2025
16 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.81 · 2022: $45.74 · 2023: $73.75 · 2024: $175 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $68.75 | 2024-2025 | |
| Blueprint Medicines Corporation | $63.17 | 2023-2025 | Ayvakit |
| Merck Sharp & Dohme LLC | $59.59 | 2022-2025 | Keytruda, Lynparza |
| Pfizer INC. | $57.85 | 2024-2025 | |
| Solventum Corporation | $57.51 | 2024-2025 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Incyte Corporation | $51.22 | 2022-2023 | Jakafi |
| Sumitomo Pharma America, INC. | $26.25 | 2025 | Orgovyx |
| Exelixis INC. | $22.78 | 2025 | Cabometyx |
| Seagen INC. | $22.78 | 2023 | Tukysa |
| Genzyme Corporation | $21.74 | 2025 | |
| Baxter Healthcare | $16.80 | 2024 | Tisseel |
| Takeda Pharmaceuticals U.S.A., INC. | $15.27 | 2024 | Alunbrig |
| Myovant Sciences INC. | $15.15 | 2021 | |
| Sobi, INC | $14.97 | 2025 | |
| Medtronic, INC. | $14.67 | 2023 | Signia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.